Certain key groups’ behaviors and perceptions towards generic drugs impact their use. Strategic educational efforts tailored to these groups can overcome barriers to use and help reduce health care costs in the United States.
This is a multiple principal investigator project between IMPAQ and Auburn University. The purpose of the research is two-fold: understand the roles of key groups and the extent of their influence on generic drug use and provide educational outreach. The expected outcomes include information, strategies, and educational materials.
This study uses a mixed-methods approach, combining a systematic review with innovative analyses of multiple publicly available datasets to determine the nature and extent of each groups’ influence. Qualitative data from key informant interviews will be used to develop and refine educational materials.
This work capitalizes on a highly-qualified, skilled, and multidisciplinary team, rich in drug regulatory policy, pharmacoepidemiology, health services research, and qualitative research expertise.